Chairman: Professor Sir John Beringer, formerly Pro Vice-Chancellor, University of Bristol

Working Groups and Convenors:

• Regulation: Mark Cantley (formerly Adviser, Life Sciences and Biotechnology, Directorate-General for Research, European Commission)
• Economic Impact : Dr Françoise Charbit, Technological Research Division, Commissariat à l'Énergie Atomique (CEA), Grenoble, France
• Communication: Professor Dr Wolfgang Heckl, Ludwig-Maximilians-Universität & Director, Deutsches Museum, Munich, Germany
• Patient Needs: Alastair Kent, Director, Genetic Interest Group, UK and Chairman, European Platform for Patients' Organisations, Science and Industry (EPPOSI)
• Ethics & Societal Impact: Professor Alfred Nordmann, Technische Universität Darmstadt, Germany & University of South Carolina, USA

Coordinator: Professor Julian Kinderlerer, Delft University of Technology, The Netherlands & University of Cape Town, South Africa, member of the European Commission's European Group on Ethics

Management: Dr David Bennett, Nanobio-RAISE EC Science & Society Project, St Edmund’s College, University of Cambridge & Delft University of Technology, The Netherlands; Dr Klaus-Michael Weltring, Nano2Life EC Network of Excellence & Bioanalytik Münster, Germany; Kuan-Ting Chi, Delft University of Technology, The Netherlands, Dr Cristina Gabellieri, European Commission

Media relations: Richard Hayhurst, Hayhurst Media, UK